Rocket Pharmaceuticals Overview
Rocket Pharmaceuticals Target Price
Analysts' 12-month price predictions for RCKT.
Share Price
$2.53
Average Target Price
$2.25
11.1% downside
11.1% downside2 analysts in the last 4 months
High: $2.5 | Low: $2
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-28 | Goldman SachsRichard Law | $2 | 20.9% downside |  |
| 2025-05-28 | JefferiesAndrew Tsai | $2.5 | 1.2% downside | |
| 2024-12-30 | WedbushYun Zhong | $32 |  1164.8% upside | |
| 2024-11-11 | Canaccord GenuityWhitney Ijem | $39 | 1441.5% upside | |
| 2024-09-18 | Canaccord GenuityWhitney Ijem | $38 | 1402% upside | |
| 2024-09-17 | Morgan StanleyMichael E Ulz | $45 | 1678.7% upside | |
| 2024-04-02 | Goldman SachsRichard Law | $39 | 1441.5% upside | |
| 2022-10-03 | Raymond James | $34 | 1243.9% upside | |
| 2022-08-09 | Raymond James | $24 | 848.6% upside | |
| 2021-08-12 | UBSEsther Rajavelu | $69 | 2627.3% upside | |